Syrrx

high-throughput protein structure determination and drug target discovery.

History:

Syrrx, founded in 1999, was acquired by Takeda Pharmaceutical in 2005.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Southern California

Research Focus:
Proteomics Disease Therapeutics-Research

 

Profiles: BioSpace CHI Hooverís

 

News: BioSpace

Keywords: 

Strategic Partnerships: